Mediwound Ltd.
A biopharmaceutical company that makes NexoBrid, a pineapple-enzyme gel that dissolves dead tissue from severe burn wounds without surgery. Founded in 2000 as a spinoff from Hebrew University of Jerusalem research into bromelain, the enzyme found in pineapple stems. The company's name plays on "medi" (medical) and "wound," reflecting its focus on wound care.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| HOLD Alapkezelo Zrt. | 13G/APassive | 10.4% | 1.35M | Aug 28, 2026 |
| T. Rowe Price Associates, Inc. | 13G/APassive | 5% | 641.1K | Aug 14, 2026 |
| Rosalind Advisors, Inc. | 13G/APassive | 7% | 912.3K | Feb 11, 2026 |
| SALAMON STEVEN A J | 13G/APassive | 7% | 912.3K | Feb 11, 2026 |
| Aharon Gil | 13G/APassive | 7% | 912.3K | Feb 11, 2026 |
| Rosalind Master Fund L.P. | 13G/APassive | 7% | 912.3K | Feb 11, 2026 |
| Yelin Lapidot Holdings Management Ltd. | 13G/APassive | 5.95% | 763.1K | Feb 5, 2026 |
| Dov Yelin | 13G/APassive | 5.95% | 763.1K | Feb 5, 2026 |
| Yair Lapidot | 13G/APassive | 5.95% | 763.1K | Feb 5, 2026 |
| Access Industries Holdings LLC | 13D/AActivist | 11.56% | 1.48M | Oct 3, 2025 |